Irina Lazariciu

Safety and efficacy of tofacitinib for up to 9.5 years in the treatment of rheumatoid arthritis: final results of a global, open-label, long-term extension study

J. Wollenhaupt, Eun-Bong Lee, Jeffrey R. Curtis et al. · Arthritis Research & Therapy · 2019 · 320 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +15

Evaluation of the Short‐, Mid‐, and Long‐Term Effects of Tofacitinib on Lymphocytes in Patients With Rheumatoid Arthritis

Ronald van Vollenhoven, Eun Bong Lee, Sander Strengholt et al. · Arthritis & Rheumatology · 2018 · 51 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Persistence of Tofacitinib in the Treatment of Rheumatoid Arthritis in Open‐Label, Long‐Term Extension Studies up to 9.5 Years

Janet Pope, Edward Keystone, Shahin Jamal et al. · ACR Open Rheumatology · 2019 · 31 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

OP0291 TOFACITINIB FOR THE TREATMENT OF POLYARTICULAR COURSE JUVENILE IDIOPATHIC ARTHRITIS: RESULTS OF A PHASE 3, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED WITHDRAWAL STUDY

Nicolino Ruperto, Tracy V. Ting, Carlos Abud‐Mendoza et al. · Annals of the Rheumatic Diseases · 2020 · 14 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Efficacy and safety of abrocitinib monotherapy in adolescents and adults: a post hoc analysis of the phase 3 JAK1 atopic dermatitis efficacy and safety (JADE) REGIMEN clinical trial

Carsten Flohr, Michael J. Cork, Michael R. Ardern‐Jones et al. · Journal of Dermatological Treatment · 2023 · 14 citations · Full text

Medicine, Dermatology, Pharmacology +15